ECSP003781A - Recubrimiento - Google Patents

Recubrimiento

Info

Publication number
ECSP003781A
ECSP003781A EC2000003781A ECSP003781A ECSP003781A EC SP003781 A ECSP003781 A EC SP003781A EC 2000003781 A EC2000003781 A EC 2000003781A EC SP003781 A ECSP003781 A EC SP003781A EC SP003781 A ECSP003781 A EC SP003781A
Authority
EC
Ecuador
Prior art keywords
starch
sugar
suspension
coating
coated tablets
Prior art date
Application number
EC2000003781A
Other languages
English (en)
Inventor
Reinhard Entner
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3525424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP003781(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ECSP003781A publication Critical patent/ECSP003781A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Glanulating (AREA)

Abstract

Un proceso para el recubrimiento de núcleos de tabletas, comprendiendo este núcleo de tableta una cantidad efectiva de cuando menos un compuesto farmacéuticamente activo, el cual comprende rociar solución o suspensión de recubrimiento que comprende un azúcar, o un almidón o una mezcla de un azúcar y un almidón sobre las tabletas o los núcleos de tabletas, con la condición de que se excluyan agentes formadores de película en la solución o suspensión de recubrimiento, para obtener tabletas recubiertas, tales como tabletas recubiertas y las mezclas de recubrimiento correspondientes.
EC2000003781A 1999-11-23 2000-11-23 Recubrimiento ECSP003781A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0198899A AT500063A1 (de) 1999-11-23 1999-11-23 Beschichtete tablettenkerne

Publications (1)

Publication Number Publication Date
ECSP003781A true ECSP003781A (es) 2002-04-23

Family

ID=3525424

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003781A ECSP003781A (es) 1999-11-23 2000-11-23 Recubrimiento

Country Status (29)

Country Link
US (1) US8652517B2 (es)
EP (1) EP1231903B1 (es)
JP (1) JP2003514848A (es)
KR (1) KR20020059771A (es)
CN (1) CN1391465A (es)
AR (1) AR026560A1 (es)
AT (2) AT500063A1 (es)
AU (1) AU776662B2 (es)
BR (1) BR0015449A (es)
CA (1) CA2387575A1 (es)
CO (1) CO5261638A1 (es)
CZ (1) CZ20021765A3 (es)
DE (1) DE60025536T2 (es)
EC (1) ECSP003781A (es)
ES (1) ES2255521T3 (es)
HK (1) HK1049786A1 (es)
HU (1) HUP0204072A3 (es)
IL (1) IL149189A0 (es)
MX (1) MXPA02005195A (es)
NO (1) NO20022362L (es)
NZ (1) NZ518524A (es)
PE (1) PE20011009A1 (es)
PL (1) PL354456A1 (es)
RU (1) RU2002116225A (es)
SK (1) SK6962002A3 (es)
TR (1) TR200201028T2 (es)
TW (1) TW579298B (es)
WO (1) WO2001037816A2 (es)
ZA (1) ZA200203654B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03007678A (es) * 2001-02-27 2004-03-16 Ranbaxy Lab Ltd Composicion farmaceutica oral de proxetil cefpodoxima.
US20030072729A1 (en) * 2001-05-15 2003-04-17 Christopher Szymczak Simethicone as weight gain enhancer
GB2380936B (en) * 2001-10-18 2003-07-09 Reckitt Benckiser Healthcare Improvements in or relating to compositions
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
CN1681493A (zh) * 2002-07-19 2005-10-12 兰贝克赛实验室有限公司 掩味舒马曲坦片剂及其制备方法
KR20040011087A (ko) * 2002-07-27 2004-02-05 주식회사 씨티씨바이오 불쾌한 맛과 향을 차폐할 수 있는 록시스로마이신 과립의제조방법
KR100523082B1 (ko) * 2002-09-11 2005-10-20 (주)다산메디켐 쓴 맛이 은폐된 세푸록심악세틸 제제의 제약조성물 및 그의 제조방법
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
PE20070077A1 (es) * 2005-06-10 2007-02-07 Takeda Pharmaceutical Comprimido con recubierta con azucar
WO2007049304A2 (en) * 2005-10-27 2007-05-03 Jubilant Organosys Limited Stable coated pharmaceutical formulation of olanzapine and process for preparing the same
EP1973549B1 (en) 2006-01-06 2016-07-20 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
JPWO2007148772A1 (ja) * 2006-06-23 2009-11-19 塩野義製薬株式会社 マクロライド系抗生物質の糖類被覆製剤
WO2007148786A1 (ja) * 2006-06-23 2007-12-27 Takeda Pharmaceutical Company Limited 安定化された固形製剤
WO2008057058A1 (en) * 2006-11-10 2008-05-15 Nobel Ilac Sanayii Ve Ticaret As Oral pharmaceutical compositions
JP5248060B2 (ja) * 2007-08-17 2013-07-31 興和株式会社 シリコーンを配合した糖衣製剤およびその製造方法
DE202009007393U1 (de) 2009-02-25 2010-07-22 Sensient Food Colors Germany Gmbh Dragiermittel zum Dragieren von Arzneimitteln und Lebensmitteln
CN102266304B (zh) * 2010-06-04 2012-12-26 瑞阳制药有限公司 苯唑西林薄膜衣片的制备方法
JP5806490B2 (ja) * 2011-03-31 2015-11-10 エスエス製薬株式会社 フィルムコーティング用組成物
WO2013151516A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Film tablet formulations comprising cefuroxime axetil and clavulanic acid
EP2882423A1 (en) 2012-08-07 2015-06-17 Sandoz AG Uncoated tablet comprising granules including a -lactam antibiotic and highly dispersed silicone dioxide
JP2014227406A (ja) * 2013-05-27 2014-12-08 株式会社ウメケン 苦味生薬含有粒状物
JP6031730B2 (ja) * 2014-12-19 2016-11-24 株式会社東洋新薬 経口剤、経口剤の製造方法、経口固形剤のコーティング用組成物
CN108815130A (zh) * 2018-08-27 2018-11-16 邓倩 一种头孢泊肟酯药片及其生产工艺
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB407919A (en) * 1932-06-24 1934-03-29 Ig Farbenindustrie Ag Improvements in or relating to the manufacture of shaped medicinal preparations
US3185628A (en) * 1960-03-18 1965-05-25 Nopco Chem Co Sunscreening dihydroxy-diphenylsulfone derivatives
US3185626A (en) * 1963-03-06 1965-05-25 Sterling Drug Inc Tablet coating method
US3361631A (en) * 1963-09-30 1968-01-02 Sandoz Ag Method of sugar coating pharmaceutical tablets
JPS4837815B1 (es) * 1970-09-25 1973-11-14 Yamanouchi Pharma Co Ltd
GB1318757A (en) * 1970-11-16 1973-05-31 Yamanouchi Pharma Co Ltd Method of sugar coating tablets
US3751277A (en) * 1971-03-24 1973-08-07 Dow Chemical Co Tablet coating process and composition
US3753767A (en) * 1971-08-02 1973-08-21 Colgate Palmolive Co Method of sugar-coating tablets
US4238510A (en) * 1979-02-21 1980-12-09 Life Savers, Inc. Sugarless coating for chewing gum and confections and method
JPS5850968B2 (ja) * 1979-04-12 1983-11-14 フロイント産業株式会社 糖衣の製法
DE2936040C2 (de) * 1979-09-06 1982-05-19 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Dragierverfahren und Mittel zur Durchführung des Verfahrens, bestehend im wesentlichen aus Saccharose, wenigstens einem weiteren Zucker und Wasser
WO1981001100A1 (fr) * 1979-10-17 1981-04-30 Roquette Freres Procede de drageification dure au sorbitol et produits ainsi obtenus
JPS57134414A (en) * 1981-02-13 1982-08-19 Nikken Kagaku Kk Preparation of sugar-coated tablet
IT1214875B (it) * 1984-06-21 1990-01-18 Ferrero Spa Prodotto confettato e procedimento per la sua fabbricazione
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
FR2580904B1 (fr) * 1985-04-30 1990-08-10 Roquette Freres Produit de confiserie ou pharmaceutique a revetement sans sucre obtenu par drageification dure et son procede de preparation.
JPS625910A (ja) * 1985-07-02 1987-01-12 Shin Etsu Chem Co Ltd 薄層糖衣錠の製造方法
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CA1316110C (en) * 1987-02-27 1993-04-13 Peter Lloyd Oren Sustained release matrix formulations
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
DD273000A1 (de) * 1988-06-20 1989-11-01 Univ Halle Wittenberg Verfahren zur herstellung von ueberzuegen auf arzneiformen
GB9104890D0 (en) 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions
US5224989A (en) * 1991-11-18 1993-07-06 Eva Likarova Film-forming dispersion for a protective coating of drug and food containing articles and objects
DE4236025A1 (de) 1992-10-24 1994-04-28 Merck Patent Gmbh Orale Arzneiformen
US5759577A (en) 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19503670C2 (de) * 1995-01-25 1997-07-31 Lichtwer Pharma Gmbh Dragiersuspension und Verfahren zur Herstellung der Dragees
US5882707A (en) * 1996-01-05 1999-03-16 Bpsi Holdings, Inc. Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate
CA2272237C (en) * 1997-01-06 2009-08-04 Berwind Pharmaceutical Services, Inc. Film coatings and film coating compositions based on dextrin
US6221402B1 (en) * 1997-11-20 2001-04-24 Pfizer Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
CA2326183A1 (en) * 1998-04-02 1999-10-14 Genencor International, Inc. Modified starch coating
DE19826517B4 (de) 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette

Also Published As

Publication number Publication date
HK1049786A1 (zh) 2003-05-30
WO2001037816A3 (en) 2001-11-29
MXPA02005195A (es) 2003-01-28
AR026560A1 (es) 2003-02-19
NO20022362L (no) 2002-07-11
AT500063A1 (de) 2005-10-15
NO20022362D0 (no) 2002-05-16
CZ20021765A3 (cs) 2002-08-14
KR20020059771A (ko) 2002-07-13
RU2002116225A (ru) 2004-01-20
ZA200203654B (en) 2003-06-05
CO5261638A1 (es) 2003-03-31
HUP0204072A3 (en) 2004-06-28
CN1391465A (zh) 2003-01-15
WO2001037816A2 (en) 2001-05-31
ATE315383T1 (de) 2006-02-15
PL354456A1 (en) 2004-01-12
HUP0204072A2 (en) 2003-05-28
US8652517B2 (en) 2014-02-18
TR200201028T2 (tr) 2002-10-21
NZ518524A (en) 2004-04-30
EP1231903B1 (en) 2006-01-11
US20060034917A1 (en) 2006-02-16
EP1231903A2 (en) 2002-08-21
IL149189A0 (en) 2002-11-10
DE60025536D1 (de) 2006-04-06
AU2358501A (en) 2001-06-04
BR0015449A (pt) 2002-07-09
CA2387575A1 (en) 2001-05-31
DE60025536T2 (de) 2006-08-10
AU776662B2 (en) 2004-09-16
ES2255521T3 (es) 2006-07-01
PE20011009A1 (es) 2001-10-18
JP2003514848A (ja) 2003-04-22
TW579298B (en) 2004-03-11
SK6962002A3 (en) 2002-10-08

Similar Documents

Publication Publication Date Title
ECSP003781A (es) Recubrimiento
GT199900203A (es) Composiciones de celecoxib.
BR0013825A (pt) Formas de apresentação de tramadol
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
DK0753506T3 (da) 6-Dimethylaminomethyl-1-phenyl-cyclohexanforbindelser som farmaceutisk aktive stoffer
WO2009072007A3 (en) Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
IT1289160B1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
UY29086A1 (es) Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos.
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
TW200700406A (en) Novel thiophene derivatives
TW200716591A (en) Novel thiophene derivatives
TW200708511A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
AR048456A2 (es) Composicion farmaceutica de topiramato
NO20013442L (no) Sammensetninger som oppnar en forbedret levering av aktive stoffer
TW200738670A (en) Novel thiophene derivatives
CO5590906A2 (es) Composiciones farmaceuticas que comprenden metformina y glibenclamida para el tratamiento de la diabetes mellitus tipo ii
DK1644376T3 (da) Pyrrolo 3,4-C pyrazol-derivater, der er aktive som kinase-inhibitorer
ECSP045286A (es) Indazoles sustituidos con una actividad anticancerosa
AR043634A1 (es) Composiciones que contienen sacaralosa
WO2009059701A3 (de) Retardtabletten mit hydromorphon
PA8576201A1 (es) Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
AR054806A1 (es) Formulaciones de estrogenos conjugados y bazedoxifeno
MX9202647A (es) Derivados de benzimidazol, metodo para la produccion de los mismo, fungicidas que contienen los mismos como ingrediente activo y compuestos intermedidos de los mismos.
GB0010446D0 (en) Pharmaceutical formulation